Fitness for Brain Optimization for Late-Life Depression
Completed · Not applicable
Conditions studied: Depression in Old Age
In brief
Cognitive impairment and brain abnormalities are common and persist after depression remission in those with Late Life Depression (LLD), compounding dementia risk in both individuals with acute and remitted LLD (rLLD). In this study, investigators will examine systemic neural and cognitive benefits of aerobic exercise training in older adults with remitted LLD. This will generate preliminary data regarding neural targets of aerobic exercise training that may translate to cognitive benefits in those with rLLD, a population who remains at high risk for dementia despite successful treatment of depression.
Key facts
- Study ID
- NCT04670510
- Run by
- University of Pittsburgh
- People needed
- 46
- Starts
- 2021-08-04
- Expected to finish
- 2025-10-22
- Last updated by the study team
- 2025-11-28
Who can join
Age: 60 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Men and women 60+ years
- Major Depressive Episode in older adulthood (since age 55)
- Current level of depressive symptoms does not meet criteria for a Major Depressive Episode
- Ambulatory without pain or the assistance of walking devices
- Able to speak and read English
- Exercise level of <100 minutes per week on average
- Medical clearance by primary care physician (PCP)
- Living in community for duration of the study
- Reliable means of transportation
- No diagnosis of a neurological disease
- Eligible to undergo MRI
You may not qualify if…
- Current diagnosis of a Major Depressive Episode
- Psychosis
- Significant suicide risk (i.e., current, active suicidal ideation with a plan)
- Electroconvulsive therapy within the past 12 months
- Engaging in moderate-intensity exercise >100 minutes per week on average
- Current treatment for cancer - except non-melanoma skin
- Neurological condition (MS, Parkinson's, Dementia, MCI) or brain injury (Stroke)
- Substance Use disorder in the past 3-months
- Current treatment for congestive heart failure, angina, uncontrolled arrhythmia, deep vein thromboses (DVT) or other cardiovascular event
- Myocardial infarction, coronary artery bypass grafting, angioplasty or other cardiac condition in the past year including uncontrolled hypertension
- Regular use of an assisted walking device
- Presence of metal implants (pacemaker, stents) that would be MR ineligible
- Claustrophobia
- Color Blindness
- Significant visual or hearing impairments that would preclude neuropsychological assessment or communication with study staff via a virtual format (videoteleconference)
- Not fluent in English
- Not medically cleared by PCP
- Traveling consecutively for 3+ weeks during the study
- MOCA (<20 to exclude) and MADRS (>9 to exclude)
Where it is running
- UPMC Western Psychiatric Hospital — Pittsburgh, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.